Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$29.85 - $39.42 $143,280 - $189,216
-4,800 Reduced 20.0%
19,200 $573,000
Q4 2023

Feb 13, 2024

SELL
$10.97 - $26.84 $10,311 - $25,229
-940 Reduced 3.77%
24,000 $611,000
Q3 2023

Nov 14, 2023

BUY
$13.9 - $23.88 $346,666 - $595,567
24,940 New
24,940 $346,000
Q1 2023

May 15, 2023

BUY
$24.84 - $38.75 $2.1 Million - $3.27 Million
84,492 New
84,492 $2.5 Million

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.01B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.